Trials

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw Annual Global Investment Conference

SOUTH SAN FRANCISCO, CA: ...

Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference

DUBLIN, IRELAND: ...

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid

DUBLIN, IRELAND: ...

Marina Biotech Expands European and Canadian Patent Protection of Its SMARTICLES Nucleic Acid Delivery Technology

BOTHELL, WA: Company to Present at the Partnering Forum During the 2015 BIO International Convention ...

Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

GEORGE TOWN, GRAND CAYMAN and FOSTER CITY, CA: Once-Daily, Dual Mechanism Antibiotic Possesses Profile to Play Key Role in Global Fight Against Antimicrobial Resistance ...

SciClone to Present at Jefferies 2015 Global Healthcare Conference on June 3, 2015

FOSTER CITY, CA: ...

Theravance Biopharma, Inc. Reports First Quarter 2015 Financial Results

GEORGE TOWN, GRAND CAYMAN: VIBATIV(R) Commercial Activities Gaining Momentum; TD-4208 Phase 3 Program to Commence Second Half 2015; New Product Candidates Advancing Towards the Clinic; Lowering Operating Loss Guidance for 2015 ...

Horizon Pharma plc Announces Waiver of Financing Proceeds Condition

DUBLIN, IRELAND and BRISBANE, CA: ...

Genetic Technologies Announces: Additional Breast Health Centres to Begin Offering BREVAGenplus(R)

MELBOURNE, AUSTRALIA: ...

Avita Medical Appoints Adam Kelliher as Chief Executive Officer

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ...